[1]Wu YW, Sullivan J, McDaniel SS, et al. Incidence of Dravet syndrome in a US population[J]. Pediatrics, 2015, 136(5): 1310-1315.
[2]Bayat A, Hjalgrim H, Moller RS, et al. The incidence of SCN1A-related Dravet syndrome in Denmark is 1:22000: a population-based study from 2004 to 2009[J]. Epilepsia, 2015, 56(4): 36-39.
[3]Shmuely S, Sisodiya SM, Gunning WB, et al. Mortality in Dravet syndrome: a review[J]. Epilepsy Behav, 2016, 64(Pt A): 69-74.
[4]黄逸青,吴原.癫痫猝死模型的研究进展[J].医学研究生学报,2016,29(1):100-103.
[5]Dravet C. Dravet syndrome history[J]. Dev Med Child Neurol, 2011, 53( Suppl 2):1-6.
[6]Scheffer IE. Diagnosis and long-term course of Dravet syndrome[J]. Eur J Paediatr Neurol, 2012, 16( Suppl 1): S5- S8
[7]Dravet C. Les e′pilepsies graves de l′enfant[J]. Vie Med,1978, 8:543-548.
[8]Dravet C. The core Dravet syndrome phenotype[J]. Epilepsia, 2011, 52(Suppl 2):3-9.
[9]Nabbout R, Desguerre I, Sabbagh S, et al. An unexpected EEG course in Dravet syndrome[J]. Epilepsy Res, 2008, 81(1):90-95.
[10]Connolly MB. Dravet syndrome: Diagnosis and long-term course[J]. Can J Neurol Sci, 2016, 43 (Suppl 3): S3-S8.
[11]Gataullina S, Dulac O. From genotype to phenotype in Dravet disease[J]. Seizure, 2017,44:58-64.
[12]Claes L, Del-favero J, ceulemans B, et al. De nove mutation in the sodium channel gene SCN1A cause severe myoclonic epileptic in fancy[J]. Am J Hum genet, 2001, 68(6):1327-1332.
[13]许小菁, 张月华, 孙慧慧, 等. Dravet综合征SCN1A基因突变的遗传特点及表型研究[J].中华医学遗传学杂志, 2012, 29(6): 625-630.
[14]Depienne C, Trouillard O, Saint-Martin C, et al. Spectrum of SCN1A gene mutations associated with Dravet syndrome: analysis of 333 patients[J]. Med Genet, 2009, 46(3): 183-191.
[15]Depienne C, Bouteiller D, Keren B, et al. Sporadic infantile epileptic encephalopathy caused by mutations in PCDH19 resembles Dravet syndrome but mainly affects females[J]. PLoS Genet, 2009, 5(2):e1000381.
[16]Patino GA, Claes LR, Lopez-Santiago LF, et al. functional null mutation of SCN1B in a patient with Dravet syndrome[J]. J Neurosci, 2009, 29(34):10764-10778.
[17]Carvill GL, Weckhuysen S, McMahon JM, et al. GABRA1 and STXBP1: novel genetic causes of Dravet syndrome[J]. Neurology, 2014, 82(14):1245-1253.
[18]Cheah CS, Yu FH, Westenbroek RE, et al. Specific deletion of NaV1.1 sodium channels ininhibitory interneurons causes seizures and premature death in amouse model of Dravet syndrome[J]. Proc Natl Acad Sci USA, 2012, 109(36):14646-14651.
[19]Grosenbaugh DK, Mott DD. Stiripentol is anticonvulsant by potentiating GABAergic transmission in a model of benzodiazepine-refractory status epilepticus[J]. Neuropharmacology, 2013, 67:136-143.
[20]Wirrell EC. Treatment of Dravet syndrome[J]. Can J Neurol Sci,2016, 43 (Suppl 3): S13-S18.
[21]Aras LM, Isla J, Mingorance-Le Meur A. The European patient with Dravet syndrome: results from a parent-reported survey on antiepileptic drug use in the European population with Dravet syndrome[J].Epilepsy Behav, 2015, 44:104-109.